Capricor Therapeutics, Inc. (CAPR)
35.28
+1.42
(+4.19%)
USD |
NASDAQ |
Apr 24, 16:00
35.05
-0.23
(-0.65%)
After-Hours: 20:00
Capricor Therapeutics EPS Diluted (Quarterly) : -0.6176 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| Repligen Corp. | 0.2345 |
| Vaxart, Inc. | 0.2289 |
| Penumbra, Inc. | 1.202 |
| Allogene Therapeutics, Inc. | -0.1717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.17M |
| Total Expenses (Quarterly) | 30.17M |
| Enterprise Value | 1.647B |
| Earnings Yield | -6.40% |
| Normalized Earnings Yield | -6.396 |